Nutanix Reports First Quarter Fiscal 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- Strong AI earnings lift S&P 500, Nasdaq as inflation data calms rate-hike jitters
- Oil prices little changed as investors weigh lower demand against US-Iran talks deadlock
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
Nutanix (NTNX) PT Raised to $38 at RBC Capital
November 26, 2019 6:17 AM ESTRBC Capital analyst Matthew Hedberg raised the price target on Nutanix (NASDAQ: NTNX) to $38.00 (from $32.00) while maintaining an Outperform rating following results.
The analyst commented, "The quarter demonstrated the consistency that we were looking for as the transition to a subscription... More
Nutanix (NTNX) Tops Q1 EPS by 4c, Revs Beat; Raises Rev Outlook
November 25, 2019 4:04 PM ESTNutanix (NASDAQ: NTNX) reported Q1 EPS of ($0.71), $0.04 better than the analyst estimate of ($0.75). Revenue for the quarter came in at $314.8 million versus the consensus estimate of $306.41 million.
Our solid Q1 performance, particularly in the Americas, gives us confidence that we have the right formula for global... More
